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Mouth breathers use the oral cavity as their principal breathing route. The main causes include: 
adenotonsillar hypertrophy and inflammatory diseases such as allergic rhinitis.
Objective: To look for atopy, the main allergens involved and to check for atopy as a comorbidity 
with the degree of hypertrophy of the tonsils and adenoids in mouth breathers.
Method: A historical cohort study with cross-sectional review of 308 medical charts of patients treated 
at a mouth breather care center of a tertiary hospital in the period of 2008-2010. We collected data on 
the mouth breather’s clinical history and we ran otolaryngological exams, flexible nasal endoscopy 
and skin prick test to aeroallergens.
Results: Of 308 patients, 36% were positive on allergy testing, with 95 % of atopic patients being 
positive for mites. Among all patients, 46% had adenoid hypertrophy; of these, 37% were atopic and 
47% had tonsillar hypertrophy, and among these, 33% were atopic.
Conclusion: We found no direct correlation between atopy and the degree of tonsils and adenoid 
hypertrophy observed among the mouth-breathing patients assessed. si.
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INTRODUCTION
Mouth breathing is a frequent complaint in pedia-
tric and ENT outpatient wards, causing great discomfort 
to the patients’ families, impairing their quality of life. 
Mouth breathing individuals replace nasal breathing 
for a mouth supplementation or a mixed breathing for 
longer than six months1,2. This condition has multiple 
causes, from nasal septum deviations to craniofacial 
deformities and tumors. The most frequent causes in 
pediatric patients are adenotonsillar hypertrophy, in-
flammatory and allergic diseases, such as allergic rhinitis 
- highly prevalent in the population3,4. Early diagnosis 
through an interdisciplinary approach is crucial for 
preventing facial growth and development disorders 
in mouth breathers.
Adenoid and tonsillar tissues are the main com-
ponents of Waldeyer’s ring, which may be enlarged 
by various causes, including infections by different 
microorganisms and allergies5-7. The role played by al-
lergy in promoting chronic inflammation with adenoid 
and tonsillar tissue hypertrophy in children remains 
unclear5,8. Atopy seems to play a different role in ton-
sils and adenoids. Tonsils have a thicker squamous 
epithelium, which hinders the penetration of antigens 
and thus suffer less of the inflammatory reaction caused 
by respiratory antigens. While the adenoid is located 
in a more limited space, in such a way that the edema 
caused by local inflammatory reaction gives rise to a 
matching greater airway obstruction9. Another factor 
that contributes to a higher action of allergens in the 
pharyngeal tonsils is the anatomical proximity of the 
nasal cavity to the nasopharynx, and the fact that these 
two regions have the same lymphatic drainage6. This 
study aimed to discuss the relationship between atopy 
and adenotonsillar hypertrophy in mouth breathers.
The objectives of this study are: to determine the 
frequency of atopy, adenotonsillar hypertrophy and 
the major allergens involved; and to investigate the 
correlation of atopy with the degree of adenotonsillar 
hypertrophy in mouth breathers evaluated in the Mouth 
Breather Care Center of a tertiary hospital.
METHOD
We ran a cross-sectional cohort study in a tertiary 
care center for mouth breathing patients. We reviewed 
the medical records and filled out the research proto-
col of all the patients seen in our service in the period 
between 2008 and 2010. This study was approved by 
the Ethics Committee of our institution, under protocol 
number 127482. It was not necessary to fill out the 
informed consent form - a procedure approved by the 
Ethics in Research Committee, because this study used 
only data from medical records, all the patients involved 
did not have their identity disclosed.
Patient inclusion criteria were: age between 3 and 
12 years, mouth breathing - assessed by the available 
clinical history and the availability of the following 
results in the medical chart: 1) Complete clinical ENT 
examination regarding tonsil size; 2) Assessment of 
patient sensitivity vis-à-vis airborne allergens by means 
of the prick test. 3) Fiberoptic endonasal examination 
to assess pharyngeal tonsil size.
The exclusion criteria were: patients who had 
associated diseases (genetic syndromes, dense deposit 
diseases, immunodeficiencies and craniofacial malfor-
mation); patients whose medical records did not have 
the necessary information for the study and patients 
already submitted to adenoid or tonsil surgery.
Upon admission, all patients were submitted 
to fiberoptic nasal endoscopy and the prick test, thus 
the data needed to complete the study protocol was 
obtained from the admission form. Of the 533 medical 
records reviewed, 50 were excluded because the pa-
tients had associated diseases (genetic syndromes, dense 
deposit diseases and immunodeficiencies), 127 because 
the medical records were incomplete and 48 did not 
meet the age criteria set for the study. Of the remaining 
308 patients who entered the study, 183 were males and 
125 were females. Their ages ranged between 3 and 12 
years, with a mean of 7.3 years. There was no pairing 
between the atopic and non-atopic patient groups, 
except for having mouth breathing and matching the 
inclusion criteria.
We used the Brodsky scale10 to assess palatine 
tonsil size. On such scale: Grade I indicates that the 
tonsil blocks less than 25% of the airway; grade II 25-
50%; 50-75% is grade III; and grade IV is associated 
with more than 75% obstruction. Patients with more 
than 50% of airway obstruction caused by the palatine 
tonsil (grades III and IV) were classified as having ton-
sillar hypertrophy.
Nasal endoscopy was performed with a 3.2 mm 
flexible fiberoptic scope, and we standardized the 
method of such examination, as well as adenoid size 
checking. For the pharyngeal tonsil assessment, the pa-
tients were divided into three groups. Group I: greater 
than 70% of cavum obstruction in at least one of the 
nostrils; Group II: 30% to 70% obstruction; and Group 
III: less than 30% obstruction of the cavum in both 
nostrils. Only those patients in Group I were classified 
as having adenoid hypertrophy.
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The prick test was carried out using the following 
standardized allergen extracts from the ALK-Abelló labo-
ratory: Dermatophagoides pteronyssinus, Dermatopha-
goides farinae, Blomia tropicalis, Canis familiaris, Felis 
domesticus, Blatella germanica, Periplaneta americana, 
Alternaria alternata, Aspergillus fumigatus, Cladospo-
rium hominis, Penicilium notatum, pollens, negative 
control (saline solution) and positive control (histamine-
-1mg/ml). The technique used was standardized by the 
European Academy of Allergy and Clinical Immunolo-
gy11. We punctured the volar surface of the forearm and 
read after 15 minutes, considering positive those skins 
papules with average diameters greater than 3 mm when 
compared to the negative control. We excluded patients 
with skin lesions, dermatographic urticaria, and those 
who used medications that could compromise the test 
result. Patients with positive skin test to at least one of 
the allergens tested were considered atopic.
We used the Fisher’s method for contingency 
statistical analysis and a p less than 0.05 was considered 
statistically significant.
RESULTS
Of the 308 mouth breathing patients selected, 110 
(36 %) were atopic and had positive skin tests to inhalant 
allergens (Graph 1). Atopic patients had the following 
skin test results: 105 (95%) patients were positive for mite 
allergens, 26 (24%) for cockroaches, seven (6%) for cat 
fur, five (5%) for dog hair, three (2%) for pollen and only 
one patient was positive for fungal antigens (Graph 2).
Graph 1. Incidence of atopy in mouth breathers.
Of the 308 mouth breathers assessed, 141 (46%) 
had adenoid hypertrophy, with the pharyngeal tonsil 
obstructing more than 70 % of the cavum, 111 (36%) 
had obstruction between 30-70% and only 56 (18%) 
had less than 30% obstruction of the cavum (Graph 3).
Graph 2. Response percentage of atopic patients to allergen extracts 
in skin prick tests.
Graph 3. Mouth breathers distribution as to adenoid size.
Of the 141 patients with adenoid hypertrophy, 
52 (37%) were considered atopic by skin test and 89 
(63%) were non-atopic; whereas patients without ade-
noid hypertrophy, 58 (35%) were atopic and 109 (65%) 
were not atopic. We carried out a statistical analysis 
using the Fisher’s contingency test as to the prevalence 
of atopy in patients with adenoid hypertrophy, whi-
ch yielded results without statistical significance (p = 
0.7213) (Graph 4).
Graph 4. Relationship between adenoid hypertrophy and atopy in 
mouth breathers.
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Also, from the 308 patients with mouth breathing, 
146 (47%) were considered with tonsillar hypertrophy, 
48 (15%) with grade IV tonsils and 98 (32%) with grade 
III tonsils. In the remaining 162 patients we noticed: 82 
(27%) with grade II tonsils and 80 (26%) with grade I 
tonsils (Graph 5).
DISCUSSION
We evaluated the frequency of atopy in patients 
with mouth breathing; 36% had positive skin tests to 
inhalant antigens, which is in agreement with other 
studies. Barros et al.1 evaluated 140 mouth breathing 
patients and found atopy in 44% of the subjects. This 
incidence is higher than its mean value found in the 
normal population - in which sensitization to allergens 
can vary from 10 to 30%12. Sadeghi-Shabestari et al.6 
found 70% positive skin reactions to aeroallergens and 
food antigens in a group of 117 children with adeno-
tonsillar hypertrophy and only 10% were positive in a 
control group of children of the same age, but without 
adenotonsillar hypertrophy. For the authors, allergic 
diseases and sensitization to different allergens are risk 
factors for adenotonsillar hypertrophy in children, and 
allergic rhinitis is among the principal causes of mouth 
breathing, since their incidence in these patients is 
substantially increased1,2,5,6,13,14.
Regarding the profile of allergens tested in the 
atopic patients, the highest rate of sensitization was 
seen to allergens of mites (95%) followed by cockroach 
allergens (24%) - and these results were similar to the 
findings reported by Barros et al.1 and Santos et al.15 in 
the Brazilian population, in Ribeirão Preto and in Belo 
Horizonte, respectively. Allergen prevalence data may 
vary according to the population studied, our sample 
was obtained from the countryside of the state of São 
Paulo, then similar to the two studies cited. Huang & 
Giannoni16, in the USA, studied 315 children with ade-
noid hypertrophy associated with allergic rhinitis and 
compared them with a control group of 315 children 
with allergic rhinitis only. The authors reported that only 
the sensitization to fungal allergens was considered a 
significant risk factor for adenoid hypertrophy. In ano-
ther study, Marek & Piotr17, found that allergic rhinitis 
can be considered a risk factor for the development of 
adenoid hypertrophy in children with atopic sensitiza-
tion to respiratory allergens.
The frequency of adenoid hypertrophy in the 
mouth breathing children evaluated was 46% and ton-
sillar hypertrophy was 47%. Of all the patients tested, 
67% had hypertrophy in at least one of the lymphoid 
tissues, which was considerably enlarged when com-
pared to the normal population; but consistent with the 
literature when compared to the study published by 
Barros et al.1, wherein the tonsil hypertrophy frequency 
was 70%. Lymphoid tissue enlargement in Waldeyer’s 
ring in children was the main cause of chronic oral 
breathing in the patients reported by Barros et al.1.
Graph 5. Mouth breathers distribution according to palatine tonsil size.
Of the 146 patients with tonsillar hypertrophy, 48 
(33%) were considered atopic by the skin test and 98 
(67%) were non-atopic; whereas in patients without ton-
sillar hypertrophy, 62 (38%) were atopic and 100 (62%) 
were not atopic. We did the statistical analysis using 
the Fisher’s contingency method as to the prevalence 
of atopy in patients with tonsillar hypertrophy, which 
did not show statistically significant results (p = 0.3426) 
(Graph 6).
Graph 6. Relationship between tonsillar hypertrophy and atopy in 
mouth breathers.
Of the 308 mouth breathers assessed, 80 had 
adenotonsillar hypertrophy, whereas 61 had only ade-
noid hypertrophy and 66 only tonsil hypertrophy. Also, 
from the total, 101 (33%) had no increase in lymphoid 
tissues and 207 (67%) had at least one hypertrophic 
tissue among all the ones considered.
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After finding a high prevalence of atopy in mouth 
breathers, we sought to identify a correlation between 
the presence and degree of tonsillar hypertrophy. No 
direct correlation between tonsil size and atopy was 
found, suggesting that other possible factors are also 
important in causing chronic inflammation in the non-
-atopic population. Carr et al.18 studied 117 patients 
with obstructive sleep apnea and adenoid hypertrophy 
and found no direct relationship between upper airway 
allergy and adenoid hypertrophy.
The high prevalence of atopy and adenotonsillar 
hypertrophy found in mouth breathers underscores 
the importance of a complete ENT and allergies as-
sessment, because these are medical conditions in 
which proper treatment will bring about quality of life 
improvements for these patients, avoiding functional 
and structural changes. Multivariate analysis studies are 
needed to identify other risk factors directly related to 
adenotonsillar chronic nonallergic inflammation and its 
consequent hypertrophy.
CONCLUSION
The frequency of atopy and adenotonsillar hyper-
trophy in the mouth breathing children evaluated in 
this study was higher when compared to the average 
found in the general population. The allergen profile 
in the study population was similar to those found in 
other Brazilian studies. There was no direct correlation 
between atopy and the degree of tonsils and adenoids 
enlargement in the mouth breathing patients evaluated.
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